Ere removed, and the inner side was whipped with cotton swaps and stained with Harris hematoxylin solution (Sigma-Aldrich). After washing, filters were cut out, mounted on microscope slides. Four images covering the majority of the sample were collected from each filter, then cells were counted using ImageJ software. Migrated B cells were counted by flow cytometry. For CFDA-SE labeling (Invitrogen), 56105 B16 tumor-primed B cells were stained with CFSE (0.5 mM, final concentration) for 15 min at 37uC and plated in 2 FBS-RPMI 1640 with or without additional 10 TCM in the transwell chamber. After 24 hrs, B cell migration and proliferation were determined by flow cytometry.RNA Isolation and Quantitative Real-time PCRTotal RNA was extracted using the RNeasy kit (Qiagen) or RNA queous-Micro Scale RNA Isolation kit (Ambion) according to the manufacturer’s instruction. RNA (0.5 to 1 mg) was reversetranscribed to cDNA using iScript cDNA Synthesis Kit (Bio-Rad), and real-time PCR reactions were performed using iQ SYBR Green supermix (Bio-Rad) on a DNA Engine thermal cycler equipped with Chromo4 detector (Bio-Rad). Gene specific primer sets were purchased from SA Bioscience. The 18S rRNA housekeeping gene was used as an internal control to normalize mRNA expression.B Cells Induce Endothelial Cell Tube Formation via StatTo further substantiate the importance of B cells with activated Stat3 in stimulating tumor angiogenesis, we performed in vivo Matrigel assays using B cells with or without intact Stat3 signaling. Matrigel plugs containing both tumor cells and Stat3+/+ B cells exhibited markedly increased tumor vascularization in vivo, compared to those with only B16 tumor cells or B cells (Fig. 2A and 2B). Although addition of Stat32/2 B cells to B16 tumor cells increased blood vessel formation somewhat, it was highly Title Loaded From File significantly less compared to that by adding Stat3+/+ B cells to B16 tumor cells (Fig. 2A, 2B and Figure S2A). Immunofluorescent staining of sections prepared from Matrigel plugs also showed the promoting effect of Stat3+/+ B cells on tumor angiogenesis (Figure S2B). Next, we assessed whether B cells and their intrinsic Stat3 signaling would affect endothelial cells’ ability in forming blood ?vessels. Co-culturing endothelial cells with naive splenic B cells significantly enhanced endothelial cell tube formation, indicating that B cells can upregulate the angiogenic potential of O check changing in the systematic bias. The calibration curve was endothelialProtein Preparation and Western Blot AnalysisCells or tissues were lysed in a modified RIPA buffer containing 50 mM Tris, pH 7.4, 1 NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4 and protease inhibitor cocktail (Roche). Tissue lysates were prepared by FastPrep homogenizor (MP Biomedicals). The lysates were clarified by centrifugation, and protein concentrations were determined by Bio-Rad protein assay. Equivalent amounts of total cellular proteins were separated by SDS plus 8?15 PAGE according to protein molecular weight, transferred onto nitrocellulose membranes, probed with the respective antibodies, and detected for signals using horseradish peroxiSTAT3-High B Cells Crucial for Tumor AngiogenesisFigure 1. B cells with activated Stat3 accelerate tumor progression and increase blood vessel formation in tumors. (A and B) Left, Growth curve of B16 (A) or LLC (B) tumors in Rag12/2 mice, without or with Stat3+/+or Stat32/2 B cells. B cells were enriched from splenocytes of B16 or LLC tumor-bearing mice with or without Stat3 ablated in hematopoietic c.Ere removed, and the inner side was whipped with cotton swaps and stained with Harris hematoxylin solution (Sigma-Aldrich). After washing, filters were cut out, mounted on microscope slides. Four images covering the majority of the sample were collected from each filter, then cells were counted using ImageJ software. Migrated B cells were counted by flow cytometry. For CFDA-SE labeling (Invitrogen), 56105 B16 tumor-primed B cells were stained with CFSE (0.5 mM, final concentration) for 15 min at 37uC and plated in 2 FBS-RPMI 1640 with or without additional 10 TCM in the transwell chamber. After 24 hrs, B cell migration and proliferation were determined by flow cytometry.RNA Isolation and Quantitative Real-time PCRTotal RNA was extracted using the RNeasy kit (Qiagen) or RNA queous-Micro Scale RNA Isolation kit (Ambion) according to the manufacturer’s instruction. RNA (0.5 to 1 mg) was reversetranscribed to cDNA using iScript cDNA Synthesis Kit (Bio-Rad), and real-time PCR reactions were performed using iQ SYBR Green supermix (Bio-Rad) on a DNA Engine thermal cycler equipped with Chromo4 detector (Bio-Rad). Gene specific primer sets were purchased from SA Bioscience. The 18S rRNA housekeeping gene was used as an internal control to normalize mRNA expression.B Cells Induce Endothelial Cell Tube Formation via StatTo further substantiate the importance of B cells with activated Stat3 in stimulating tumor angiogenesis, we performed in vivo Matrigel assays using B cells with or without intact Stat3 signaling. Matrigel plugs containing both tumor cells and Stat3+/+ B cells exhibited markedly increased tumor vascularization in vivo, compared to those with only B16 tumor cells or B cells (Fig. 2A and 2B). Although addition of Stat32/2 B cells to B16 tumor cells increased blood vessel formation somewhat, it was highly significantly less compared to that by adding Stat3+/+ B cells to B16 tumor cells (Fig. 2A, 2B and Figure S2A). Immunofluorescent staining of sections prepared from Matrigel plugs also showed the promoting effect of Stat3+/+ B cells on tumor angiogenesis (Figure S2B). Next, we assessed whether B cells and their intrinsic Stat3 signaling would affect endothelial cells’ ability in forming blood ?vessels. Co-culturing endothelial cells with naive splenic B cells significantly enhanced endothelial cell tube formation, indicating that B cells can upregulate the angiogenic potential of endothelialProtein Preparation and Western Blot AnalysisCells or tissues were lysed in a modified RIPA buffer containing 50 mM Tris, pH 7.4, 1 NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4 and protease inhibitor cocktail (Roche). Tissue lysates were prepared by FastPrep homogenizor (MP Biomedicals). The lysates were clarified by centrifugation, and protein concentrations were determined by Bio-Rad protein assay. Equivalent amounts of total cellular proteins were separated by SDS plus 8?15 PAGE according to protein molecular weight, transferred onto nitrocellulose membranes, probed with the respective antibodies, and detected for signals using horseradish peroxiSTAT3-High B Cells Crucial for Tumor AngiogenesisFigure 1. B cells with activated Stat3 accelerate tumor progression and increase blood vessel formation in tumors. (A and B) Left, Growth curve of B16 (A) or LLC (B) tumors in Rag12/2 mice, without or with Stat3+/+or Stat32/2 B cells. B cells were enriched from splenocytes of B16 or LLC tumor-bearing mice with or without Stat3 ablated in hematopoietic c.

Loop (E3) region near the channel pore [26]. The specificity of E3-targeting antibodies was tested by ELISA, Western blotting and functional assays, and fluorescence activated cell sorting (FACS) [9,26]. The procedure for Western blotting has been described previously [26]. Briefly, cells were lysed in RIPA buffer (Sigma-Aldrich, Poole, UK) and proteins were separated on 10 SDS-PAGE gel before transferring onto nitrocellulose membrane. The blot was incubated with rabbit anti-TRPC antibodies (1:200) overnight at 4uC, washed with phosphate buffered saline (PBS), and incubated with goat antirabbit IgG-HRP at 1:2000 dilution (Sigma). The rabbit anti-bactin (Santa Cruz Biotech, USA) at 1:400 dilution was used as an internal standard for protein quantification. Visualization was carried out using ECLplus detection reagents (GE Healthcare, UK) and exposure to X-ray films. The quantification was analysed using Image J software (NIH, USA). The immunostaining procedure was similar to our reports [9,27] and the VECTASTAIN ABC system (Vector Laboratories, Peterborough, UK) was used. The rabbit anti-TRPC1, 3, 4 and 6 antibodies purchased from Abcam (Cambridge, UK) were used for human lung tissue and lung purchase SR-3029 cancer section staining. The staining quantification was assessed by scoring positive stained cells and staining intensity ranked as 16985061 0 (negative), 1 (weak), 2 (intermediate) and 3 (strong) [28].Cells Culture and Gene TransfectionA549 cell line, a commonly used lung cancer cell model derived from adenocarcinomic human alveolar basal epithelial cells, was grown in DMEM/F12 medium (Invitrogen, Paisley, UK) containing 10 foetal bovine serum (FBS), 100 units/ml penicillin and 100 mg/ml streptomycin, and maintained at 37uC under 95 air and 5 CO2. Human TRPC1, TRPC3 and TRPC6 were amplified from the cDNA of human ovarian cancer cells and human TRPC4 were amplified from the cDNA of human aortic endothelial cells with 100 identity to the sequences in the Genbank (accession numbers: X89066 (TRPC1); U47050 (TRPC3), NM_016179 (TRPC4a) and BC093660 (TRPC6). The TRPC cDNAs were subcloned into pcDNA3.1 or pEGFPC1 vectors and their functional expression has been confirmed as we reported [9]. A549 cells were transfected with TRPC1, 3, 4, and 6 plasmid cDNAs in pcDNA3 vector using LipofectaTRPC in Lung Cancer DifferentiationFigure 1. Distribution of TRPC isoforms in human lung and lung cancer. A, Examples of human 4 IBP web normal lung (n = 20) and lung cancer tissue sections (n = 28) including adenocarcinoma (AC) and squamous cell carcinoma (SCC) were stained with anti-TRPC1, anti-TRPC3, anti-TRPC4 and antiTRPC6 antibodies using VECTASTAIN ABC system. The positive staining was shown as brown colour. The nuclei were counter-stained by hematoxylin. B, The mRNA was detected by real-time PCR in normal lung tissues using the primers in Table S1. The GAPDH was used as internal house-keeping gene control for quantification (n = 25 patients for TRPC1, 4, 5 and 6 groups; n = 24 for TRPC3; and n = 9 for TRPC7). C, The mRNA levels in lung cancer tissues (AC: n = 9?5; SCC: n = 8?1). doi:10.1371/journal.pone.0067637.gWhole-cell Patch ClampThe whole cell currents were recorded using Axoclamp 2B or Axopatch B200 patch clamp amplifier and controlled with pClamp 10 software. The procedures for recording TRPCcurrents were similar to our previous reports [29,30]. A 1-s ramp voltage protocol from ?00 mV to +100 mV was applied at a frequency of 0.2 Hz from a holding potential of 0 mV. Signa.Loop (E3) region near the channel pore [26]. The specificity of E3-targeting antibodies was tested by ELISA, Western blotting and functional assays, and fluorescence activated cell sorting (FACS) [9,26]. The procedure for Western blotting has been described previously [26]. Briefly, cells were lysed in RIPA buffer (Sigma-Aldrich, Poole, UK) and proteins were separated on 10 SDS-PAGE gel before transferring onto nitrocellulose membrane. The blot was incubated with rabbit anti-TRPC antibodies (1:200) overnight at 4uC, washed with phosphate buffered saline (PBS), and incubated with goat antirabbit IgG-HRP at 1:2000 dilution (Sigma). The rabbit anti-bactin (Santa Cruz Biotech, USA) at 1:400 dilution was used as an internal standard for protein quantification. Visualization was carried out using ECLplus detection reagents (GE Healthcare, UK) and exposure to X-ray films. The quantification was analysed using Image J software (NIH, USA). The immunostaining procedure was similar to our reports [9,27] and the VECTASTAIN ABC system (Vector Laboratories, Peterborough, UK) was used. The rabbit anti-TRPC1, 3, 4 and 6 antibodies purchased from Abcam (Cambridge, UK) were used for human lung tissue and lung cancer section staining. The staining quantification was assessed by scoring positive stained cells and staining intensity ranked as 16985061 0 (negative), 1 (weak), 2 (intermediate) and 3 (strong) [28].Cells Culture and Gene TransfectionA549 cell line, a commonly used lung cancer cell model derived from adenocarcinomic human alveolar basal epithelial cells, was grown in DMEM/F12 medium (Invitrogen, Paisley, UK) containing 10 foetal bovine serum (FBS), 100 units/ml penicillin and 100 mg/ml streptomycin, and maintained at 37uC under 95 air and 5 CO2. Human TRPC1, TRPC3 and TRPC6 were amplified from the cDNA of human ovarian cancer cells and human TRPC4 were amplified from the cDNA of human aortic endothelial cells with 100 identity to the sequences in the Genbank (accession numbers: X89066 (TRPC1); U47050 (TRPC3), NM_016179 (TRPC4a) and BC093660 (TRPC6). The TRPC cDNAs were subcloned into pcDNA3.1 or pEGFPC1 vectors and their functional expression has been confirmed as we reported [9]. A549 cells were transfected with TRPC1, 3, 4, and 6 plasmid cDNAs in pcDNA3 vector using LipofectaTRPC in Lung Cancer DifferentiationFigure 1. Distribution of TRPC isoforms in human lung and lung cancer. A, Examples of human normal lung (n = 20) and lung cancer tissue sections (n = 28) including adenocarcinoma (AC) and squamous cell carcinoma (SCC) were stained with anti-TRPC1, anti-TRPC3, anti-TRPC4 and antiTRPC6 antibodies using VECTASTAIN ABC system. The positive staining was shown as brown colour. The nuclei were counter-stained by hematoxylin. B, The mRNA was detected by real-time PCR in normal lung tissues using the primers in Table S1. The GAPDH was used as internal house-keeping gene control for quantification (n = 25 patients for TRPC1, 4, 5 and 6 groups; n = 24 for TRPC3; and n = 9 for TRPC7). C, The mRNA levels in lung cancer tissues (AC: n = 9?5; SCC: n = 8?1). doi:10.1371/journal.pone.0067637.gWhole-cell Patch ClampThe whole cell currents were recorded using Axoclamp 2B or Axopatch B200 patch clamp amplifier and controlled with pClamp 10 software. The procedures for recording TRPCcurrents were similar to our previous reports [29,30]. A 1-s ramp voltage protocol from ?00 mV to +100 mV was applied at a frequency of 0.2 Hz from a holding potential of 0 mV. Signa.

Ression of ICAM-1 has been observed in rats with monocrotaline injection [26]- and chronic hypoxia exposure [27?8]-induced PH. Moreover, increased flow pulsatility has been shown to induce endothelial expression of inflammatoryInflammation and HO-1 in Right Ventricular FailureFigure 2. Morphometry on smallest pulmonary arterioles (,75 micrometers) obtained in Sham and Shunt piglets and labeled by the method of von Gieson-orcein. At least 50 resistive arterioles have been measured per animal. The medial thickness (MT) has been reported in vessel diameter following the formula MT = [(26 MT)/ED]6100 where ED is the external diameter of arterioles measured. MT in pulmonary arteries under 75 micrometers correlated to lung tissue relative IL-19 mRNA content. Values expressed as mean6SEM. doi:10.1371/journal.pone.0069470.ggenes, including ICAM-1 [29], suggesting that prolonged shuntinduced overcirculation could contribute to the development of an inflammatory phenotype in the lungs of the present experimental model. In accordance with the present results showing a tight BIBS39 relation between pulmonary ICAM-1 expression and the PVR, the severity of the pulmonary hypertensive disease has been tightly correlated to serum level of soluble ICAM-1 in patients with congenital heart disease and PH [2]. In the present experimental model of PAH, IL-33 was overexpressed in the lungs, while expression of its ST2 receptor remained unchanged. Recently described member of the IL-1 cytokine family, IL-33 is a strong inducer of T helper 2 (Th2) immune responses [30] and contributes to the early events in endothelial activation, promoting endothelial expression of adhesion molecules (e.a. ICAM-1 and VCAM-1) and pro-inflammatory chemokines (e.a. monocyte chemoattractant protein-1) [31]. IL-33 could therefore contribute to the endothelial activation and subsequent pulmonary arterial remodeling in PAH. Normally released by necrotic cells as an “alarming factor” alerting the immune system to tissue damage or stress, mechanical strain hasalso been shown to induce the secretion of IL-33 in fibroblasts in the absence of cellular necrosis [32]. Via its 548-04-9 web binding to the ST2 receptor, IL-33 also strongly induces Th2 cytokine production (e.a. IL-4, -13 and -19) from these cells and can promote the pathogenesis of Th2-related disease, such as pulmonary arterial remodeling [33]. Six-month systemic-to-pulmonary shunting increased pulmonary expression of IL-19, while STAT3 expression did not change. This could be seen as a Th2-related cytokine production. In vascular smooth muscle cells, IL-19 rapidly evokes the activation and the translocation of STAT3 transcription factor [34] which has been recently incriminated in the development of idiopathic PAH [35] and experimental monocrotaline injection-induced PH [36]. IL-19 also induces the expression of the potent inflammatory modulator HO-1 1317923 and decreases the production of reactive oxygen species in human vascular smooth muscle cells [17]. IL-19 has been shown to decrease dose-dependently the proliferation of vascular smooth muscle cells [15,34,37?8], whereas, in endothelial cell, HO-1 induction increases cell cycle progression [39]. Increased pulmonary IL-19 expression could be therefore partlyInflammation and HO-1 in Right Ventricular FailureFigure 3. Panel A: Relative lung tissue mRNA content for the heme-oxygenase(HO)-1 and -2 tumor necrosis factor(TNF)-a, intercellular adhesion molecule(ICAM)-1 and -2, vascular cell adhesion mol.Ression of ICAM-1 has been observed in rats with monocrotaline injection [26]- and chronic hypoxia exposure [27?8]-induced PH. Moreover, increased flow pulsatility has been shown to induce endothelial expression of inflammatoryInflammation and HO-1 in Right Ventricular FailureFigure 2. Morphometry on smallest pulmonary arterioles (,75 micrometers) obtained in Sham and Shunt piglets and labeled by the method of von Gieson-orcein. At least 50 resistive arterioles have been measured per animal. The medial thickness (MT) has been reported in vessel diameter following the formula MT = [(26 MT)/ED]6100 where ED is the external diameter of arterioles measured. MT in pulmonary arteries under 75 micrometers correlated to lung tissue relative IL-19 mRNA content. Values expressed as mean6SEM. doi:10.1371/journal.pone.0069470.ggenes, including ICAM-1 [29], suggesting that prolonged shuntinduced overcirculation could contribute to the development of an inflammatory phenotype in the lungs of the present experimental model. In accordance with the present results showing a tight relation between pulmonary ICAM-1 expression and the PVR, the severity of the pulmonary hypertensive disease has been tightly correlated to serum level of soluble ICAM-1 in patients with congenital heart disease and PH [2]. In the present experimental model of PAH, IL-33 was overexpressed in the lungs, while expression of its ST2 receptor remained unchanged. Recently described member of the IL-1 cytokine family, IL-33 is a strong inducer of T helper 2 (Th2) immune responses [30] and contributes to the early events in endothelial activation, promoting endothelial expression of adhesion molecules (e.a. ICAM-1 and VCAM-1) and pro-inflammatory chemokines (e.a. monocyte chemoattractant protein-1) [31]. IL-33 could therefore contribute to the endothelial activation and subsequent pulmonary arterial remodeling in PAH. Normally released by necrotic cells as an “alarming factor” alerting the immune system to tissue damage or stress, mechanical strain hasalso been shown to induce the secretion of IL-33 in fibroblasts in the absence of cellular necrosis [32]. Via its binding to the ST2 receptor, IL-33 also strongly induces Th2 cytokine production (e.a. IL-4, -13 and -19) from these cells and can promote the pathogenesis of Th2-related disease, such as pulmonary arterial remodeling [33]. Six-month systemic-to-pulmonary shunting increased pulmonary expression of IL-19, while STAT3 expression did not change. This could be seen as a Th2-related cytokine production. In vascular smooth muscle cells, IL-19 rapidly evokes the activation and the translocation of STAT3 transcription factor [34] which has been recently incriminated in the development of idiopathic PAH [35] and experimental monocrotaline injection-induced PH [36]. IL-19 also induces the expression of the potent inflammatory modulator HO-1 1317923 and decreases the production of reactive oxygen species in human vascular smooth muscle cells [17]. IL-19 has been shown to decrease dose-dependently the proliferation of vascular smooth muscle cells [15,34,37?8], whereas, in endothelial cell, HO-1 induction increases cell cycle progression [39]. Increased pulmonary IL-19 expression could be therefore partlyInflammation and HO-1 in Right Ventricular FailureFigure 3. Panel A: Relative lung tissue mRNA content for the heme-oxygenase(HO)-1 and -2 tumor necrosis factor(TNF)-a, intercellular adhesion molecule(ICAM)-1 and -2, vascular cell adhesion mol.

In HepG2 cells, we constructed HepG2-PXR cell line that stably overexpresses PXR in order to better study the effect of PXR on lipogenesis. Human PXR expression plasmid, pCMV-3Xflag-PXR, and control vector plasmid, pCMV-3Xflag, were transfected into HepG2 cells, which were then selected by G418 for 14 days. The cell colonies were selected and expanded. The PXR and vector cell lines were named HepG2-PXR and HepG2-Vector, respectively. The expression of PXR at both mRNA and protein levels was verified. RT-PCR analysis showed that the mRNA level of PXR in HepG2-PXR cells was much higher than in HepG2-Vector cells (125-65-5 Figure 4A). The PXR protein expression was confirmed by western blot analysis using an anti-PXR antibody (Figure 4B) and an anti-flag antibody (Figure 4C), and by immunofluorescence using an anti-PXR antibody (Figure 4D). To functionally test the stable cells, pCYP3A4-Luc was transfected into HepG2-PXR and HepG2-Vector cells and the transfected cells were treated by rifampicin. As expected, compared with HepG2-vector cells, the transcriptional activity of PXR on the CYP3A4 promoter reporter gene was significantly higher in HepG2-PXR cells after I-BRD9 chemical information rifampicin activation (Figure 4E). The basal reporter activity in HepG2PXR cells was also higher than HepG2-Vector cells (Figure 4E). These results were consistent with the cellular localization of PXR in HepG2-PXR cells. As shown in immunochemistry staining, even in the absence of rifampicin, most PXR protein was located in the 1315463 nucleus (Figure 5), while in HepG2-Vector cells, PXR was evenly distributed within the cells (Figure 5). Upon rifampicin incubation, PXR translocated into the nucleus in both HepG2Vector and HepG2-PXR cells (Figure 5).DiscussionIn this study, we showed that rifampicin induced lipid accumulation in HepG2 cells through the up-regulation of several genes involved in hepatic lipid uptake and lipogenesis, such as the free fatty acid transporter CD36 and lipogenic enzymes FAE and SCD1. We also established SCD1 as a direct transcriptional target of PXR. PXR overexpression and activation in VP-hPXR transgenic mice caused hepatic steatosis, which is characterized by a marked accumulation of hepatic triglycerides [23]. This is a result from combined effect of PXR activation on increased hepatic free fatty acid uptake, lipogenesis and suppression of b-oxidation [23]. The PXR-mediated lipogenesis in rodents is independent of SREBP1c, which is distinct from that mediated by LXR [7,33]. However,The Expression of SCD1 was Induced in HepG2-PXR CellsWe next examined the expression of genes involved in lipid homeostasis in HepG2-PXR and HepG2-Vector cells with or without rifampicin incubation. As expected, the expression of CD36, ABCG1, FAE, SCD1, LCAT and CYP3A4 was increased in both cell lines after rifampicin treatment (Figure 6A), which was consistent with the results in the parent HepG2 cells. Moreover, the expression of these genes in HepG2-PXR cells was higher than in HepG2-Vector cells (Figure 6A). The relativeSCD1 Contributes to the Lipogenic Effect by PXRthe effect of PXR on lipogenesis in human liver cells has not been reported. In the current study, although the triglyceride level in HepG2 cells was not changed by rifampicin (Figure 2C), the total cholesterol level was increased (Figure 2D), mainly due to the increased cholesterol ester in HepG2 cells (Figure 2E and 2F). Consistent with these observations, the expression of LCAT, an enzyme that converts free cholesterol.In HepG2 cells, we constructed HepG2-PXR cell line that stably overexpresses PXR in order to better study the effect of PXR on lipogenesis. Human PXR expression plasmid, pCMV-3Xflag-PXR, and control vector plasmid, pCMV-3Xflag, were transfected into HepG2 cells, which were then selected by G418 for 14 days. The cell colonies were selected and expanded. The PXR and vector cell lines were named HepG2-PXR and HepG2-Vector, respectively. The expression of PXR at both mRNA and protein levels was verified. RT-PCR analysis showed that the mRNA level of PXR in HepG2-PXR cells was much higher than in HepG2-Vector cells (Figure 4A). The PXR protein expression was confirmed by western blot analysis using an anti-PXR antibody (Figure 4B) and an anti-flag antibody (Figure 4C), and by immunofluorescence using an anti-PXR antibody (Figure 4D). To functionally test the stable cells, pCYP3A4-Luc was transfected into HepG2-PXR and HepG2-Vector cells and the transfected cells were treated by rifampicin. As expected, compared with HepG2-vector cells, the transcriptional activity of PXR on the CYP3A4 promoter reporter gene was significantly higher in HepG2-PXR cells after rifampicin activation (Figure 4E). The basal reporter activity in HepG2PXR cells was also higher than HepG2-Vector cells (Figure 4E). These results were consistent with the cellular localization of PXR in HepG2-PXR cells. As shown in immunochemistry staining, even in the absence of rifampicin, most PXR protein was located in the 1315463 nucleus (Figure 5), while in HepG2-Vector cells, PXR was evenly distributed within the cells (Figure 5). Upon rifampicin incubation, PXR translocated into the nucleus in both HepG2Vector and HepG2-PXR cells (Figure 5).DiscussionIn this study, we showed that rifampicin induced lipid accumulation in HepG2 cells through the up-regulation of several genes involved in hepatic lipid uptake and lipogenesis, such as the free fatty acid transporter CD36 and lipogenic enzymes FAE and SCD1. We also established SCD1 as a direct transcriptional target of PXR. PXR overexpression and activation in VP-hPXR transgenic mice caused hepatic steatosis, which is characterized by a marked accumulation of hepatic triglycerides [23]. This is a result from combined effect of PXR activation on increased hepatic free fatty acid uptake, lipogenesis and suppression of b-oxidation [23]. The PXR-mediated lipogenesis in rodents is independent of SREBP1c, which is distinct from that mediated by LXR [7,33]. However,The Expression of SCD1 was Induced in HepG2-PXR CellsWe next examined the expression of genes involved in lipid homeostasis in HepG2-PXR and HepG2-Vector cells with or without rifampicin incubation. As expected, the expression of CD36, ABCG1, FAE, SCD1, LCAT and CYP3A4 was increased in both cell lines after rifampicin treatment (Figure 6A), which was consistent with the results in the parent HepG2 cells. Moreover, the expression of these genes in HepG2-PXR cells was higher than in HepG2-Vector cells (Figure 6A). The relativeSCD1 Contributes to the Lipogenic Effect by PXRthe effect of PXR on lipogenesis in human liver cells has not been reported. In the current study, although the triglyceride level in HepG2 cells was not changed by rifampicin (Figure 2C), the total cholesterol level was increased (Figure 2D), mainly due to the increased cholesterol ester in HepG2 cells (Figure 2E and 2F). Consistent with these observations, the expression of LCAT, an enzyme that converts free cholesterol.

netic abnormalities, as well as non-genetic causes, including the environment, environmental and gene interaction and metabolic disturbances, with the recurrence risk dependent on the family history and presence or absence of dysmorphic features. Candidate genes for ASD are identified by different means, including cytogenetic abnormalities indicating the location or loss of specific genes) in HC-067047 chemical information individuals with ASD along with overlapping linkage and functional data related to the clinical presentation, with certain chromosome regions identified by genetic linkage using DNA markers that co-inherit with the specific phenotype. A representative example for such an occurrence is the proto-oncogene involved in pathways related to neuronal development and found to be linked to the chromosome 7q31 band, where this gene is located. Decreased activity of the gene promoter was recognized when specific single nucleotide polymorphisms were present in this region by linkage studies. Int. J. Mol. Sci. 2015, 16 6466 However, genetic linkage studies have received only limited success in the study of the genetics of autism. On the other hand, chromosomal microarray analysis using DNA probes disturbed across the genome can be used to detect chromosomal abnormalities at >100-times smaller than seen in high-resolution chromosome studies. Microarray studies have also become the first tier of genetic testing for this patient population and are recommended for all ASD patients. Greater than 20% of studied patients with microarray analysis are found to have submicroscopic deletions or duplications in the genome containing genes that play a role in causing autism. Identification of causative mutations is important to guide treatment selection and to manage PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/1981885 medical co-morbidities, such as risks for seizures, developmental regression or for cancer. Routine cytogenetic studies have shown abnormalities of chromosomes 2, 3, 4, 5, 7, 8, 11, 13, 15, 16, 17, 19, 22 and X, including deletions, duplications, translocations and inversions involving specific chromosome regions where known or candidate genes for ASD are located. These studies further support the role of genetic factors in the causation of this common neurodevelopment disorder. Specifically, cytogenetic abnormalities involving the 15q11q13 region are found in at least 1% of individuals with ASD and include CYFIP1, GABRB3 and UBE3A genes in this chromosome region and most recently the 15q11.2 BP1-BP2 microdeletion syndrome. DNA copy number changes have also shown recurrent small deletions or duplications of the chromosome 16p11.2 band using microarray analysis and the chromosome 15q13.2q13.3 region, whereas copy number changes are noted throughout the genome in individuals with ASD, indicating the presence of multiple candidate genes on every human chromosome. These copy number changes are more often of the deletion type. For idiopathic or non-syndromic autism, the empirical risk for siblings to be similarly affected is between 2% and 8% with an average of 4%. In multiplex families having two or more affected children with autism, the recurrence risk may be as high as 25%, but generally ranges from 13% to 19% if due to single-gene disturbances as the cause, a major focus of this illustrative review. Advances in genetic technology beyond linkage or cytogenetic analysis of affected families with ASD or other complex disorders have led to genome-wide association studies involving hundreds of affected and control i

in the replication analysis. This was likely due to the inclusion of one study that had imputed to the combined HapMap + 1000G panel, whereas all other studies with imputed data had imputed to HapMap. To increase order 345627-80-7 homogeneity, we performed several sensitivity analyses. First, we reran the discovery meta-analysis excluding the MAAS study. This analysis did not materially change our findings, with one additional SNP reaching the subthreshold level of significance and five SNPs losing significance. None of these five SNPs had replicated in the primary analysis. Second, we reran the replication and joint meta-analysis including only those cohorts that imputed to 1000G. Results of this analysis were very similar to the primary analysis, with two additional replicated SNPs, rs17309930 near BDNF and rs13107325 in SLC39A8. Both of these are known loci for adult BMI. Third, we reran the replication including only the HapMap-imputed and unimputed studies. The results were very similar to those using all studies, with rs4870949 and rs2590942 PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19821824 now passing the significance threshold and rs8092503 and rs3829849 now just above it. rs1573972 was not replicated in any of the analyses. As results of the third and fourth sensitivity analyses were very similar to those including all replication cohorts, we used the latter as our main analysis for reasons of power. Statistical approach Cohort-specific genome-wide association analyses were first run in the discovery cohorts, using high-density Illumina or Affymetrix SNP arrays, followed by imputation to the HapMap CEU release 22 imputation panel. The MAAS study imputed to the combined 1000 Genomes Pilot + HapMap 3 panel. Before imputation, studies applied studyspecific quality filters on samples and SNP call rate, minor allele frequency and HardyWeinberg disequilibrium. Leipzig, NFBC1986, STRIP and PANIC contributed unimputed data from the Metabochip. Linear regression models assuming an additive genetic model were run in each study, to assess the association of each SNP with SDSBMI, adjusting for principal components if this was deemed needed in the individual studies. As SDSBMI is age and sex specific, no further adjustments were made. Before the meta-analysis, we applied quality filters to each study, filtering out SNPs with a minor allele frequency below 1% and SNPs with poor imputation quality. For studies contributing unimputed metabochip data to the discovery analysis, we excluded SNPs with a SNP call rate of <0.95 Genetic risk score and percentage of variance explained A weighted risk score was computed as the sum of the number of SDSBMI-increasing alleles weighted by the effect sizes from the discovery meta-analysis. Then, the score was rescaled to range from zero to the maximum number of SDS BMI-increasing alleles and rounded to the nearest integer. The association of the risk score with 398 | Human Molecular Genetics, 2016, Vol. 25, No. 2 SDSBMI was assessed in one of the largest replication cohorts by running a linear regression model. The variance in SDSBMI explained by the risk score was estimated by the unadjusted R 2 of this model. The percentage of variance in adult BMI explained by the 15 SNPs was calculated using the published data from the recently published large meta-analysis of GWAs studies on adult BMI. For each SNP, the variance explained was calculated as: 2 MAF , and these variances were then summed to give the total percentage of variance in adult BMI explained by the 15 SNPs. LD sc

Been immobilized by levamisole were captured at 60X magnification using a high resolution wide field Core DV system (Applied PrecisionTM; Oregon Health and Sciences University Advanced 10781694 Light Microscopy Core Facility, Portland, OR). Deconvolution-optimized images were used to quantify relative ROS levels by manually enclosing the terminal pharyngeal bulb within each image and obtaining the maximum intensity of the area using ImageJ software (National Institutes of Health). Final ROS levels for each line were Autophagy calculated as the difference between pharyngeal bulb intensity in labeled and unlabeled control worms from each line.(iii) Measurement of 8-oxodG Levels by Enzyme-Linked ImmunoSorbent Assay (ELISA)We measured oxidative damage in 12-day-old nematodes because oxidative damage in general is more reliably detected in older nematodes [44,45] and significant differences in steady-state 8-oxodG content have been harder to detect in young adult [39] and mixed-stage nematodes [46]. Additionally, our preliminary work with a mutant strain (the mev-1 mutant strain) that has constitutively elevated oxidative stress [47,48] indicated that while steady-state ROS levels were significantly elevated in mev-1 compared to N2 individuals in the young adult stage (S.E., unpubl. results), differences in 8-oxodG were not detected in young adult nematodes (J.J.-M., unpubl. results). Frozen stocks for the MA lines and G0 ancestor were thawed; five individuals from each line were randomly selected to initiate biological replicates, which were carried through three generations of Autophagy single-individual descent in standard conditions and then expanded to a large population and age-synchronized [33]. Upon reaching the L4 larval stage, each population (five populations for each MA line and the G0 ancestor) was transferred to NGM plates containing 40 mM 5-fluoro-29-deoxyuridine (FUdR) to prevent mixing of the focal population with its progeny. FUdR inhibits DNA and RNA synthesis; since most of the cells in an adult nematode are postmitotic, treatment with FUdR inhibits the production of viable progeny and is routinely used in studies of wild-type and mutant nematode strains [38,49,50,51,52]. While FUdR treatment does affect an assortment of metabolic processes in C. elegans [53] and likely alters mitochondrial DNA replication and mitochondrial biogenesis, it is not clear whether FUdR treatment can be expected to alter oxidative stress since it did not alter mitochondrial morphology [54] or antioxidant enzyme expression [55] in(ii) Measurement of Steady-state Reactive Oxygen Species (ROS) Levels by Confocal MicroscopyCryogenically preserved stocks of the MA lines (G250) and common ancestor (G0) were thawed and nematodes were allowed to recover for one week under standard laboratory conditions at 20uC, with regular population transfers to fresh 15 mm nematode growth medium (NGM) Petri plates inoculated with OP50-1 Escherichia coli. Two independent, age-synchronous populations of each line were generated by bleaching [33]; half of each population was reserved to create line-specific internal controlRelaxed Selection and Oxidative Stressnematodes. All nematodes were maintained on FUdR-containing plates until they were 12 days old, at which point the nematodes were washed in M9 buffer, flash-frozen and stored at 280uC. To minimize DNA oxidation during sample preparation [56], we used the chaotropic sodium iodide method [57] with a DNA Extractor TIS kit (Wako) with lengthened.Been immobilized by levamisole were captured at 60X magnification using a high resolution wide field Core DV system (Applied PrecisionTM; Oregon Health and Sciences University Advanced 10781694 Light Microscopy Core Facility, Portland, OR). Deconvolution-optimized images were used to quantify relative ROS levels by manually enclosing the terminal pharyngeal bulb within each image and obtaining the maximum intensity of the area using ImageJ software (National Institutes of Health). Final ROS levels for each line were calculated as the difference between pharyngeal bulb intensity in labeled and unlabeled control worms from each line.(iii) Measurement of 8-oxodG Levels by Enzyme-Linked ImmunoSorbent Assay (ELISA)We measured oxidative damage in 12-day-old nematodes because oxidative damage in general is more reliably detected in older nematodes [44,45] and significant differences in steady-state 8-oxodG content have been harder to detect in young adult [39] and mixed-stage nematodes [46]. Additionally, our preliminary work with a mutant strain (the mev-1 mutant strain) that has constitutively elevated oxidative stress [47,48] indicated that while steady-state ROS levels were significantly elevated in mev-1 compared to N2 individuals in the young adult stage (S.E., unpubl. results), differences in 8-oxodG were not detected in young adult nematodes (J.J.-M., unpubl. results). Frozen stocks for the MA lines and G0 ancestor were thawed; five individuals from each line were randomly selected to initiate biological replicates, which were carried through three generations of single-individual descent in standard conditions and then expanded to a large population and age-synchronized [33]. Upon reaching the L4 larval stage, each population (five populations for each MA line and the G0 ancestor) was transferred to NGM plates containing 40 mM 5-fluoro-29-deoxyuridine (FUdR) to prevent mixing of the focal population with its progeny. FUdR inhibits DNA and RNA synthesis; since most of the cells in an adult nematode are postmitotic, treatment with FUdR inhibits the production of viable progeny and is routinely used in studies of wild-type and mutant nematode strains [38,49,50,51,52]. While FUdR treatment does affect an assortment of metabolic processes in C. elegans [53] and likely alters mitochondrial DNA replication and mitochondrial biogenesis, it is not clear whether FUdR treatment can be expected to alter oxidative stress since it did not alter mitochondrial morphology [54] or antioxidant enzyme expression [55] in(ii) Measurement of Steady-state Reactive Oxygen Species (ROS) Levels by Confocal MicroscopyCryogenically preserved stocks of the MA lines (G250) and common ancestor (G0) were thawed and nematodes were allowed to recover for one week under standard laboratory conditions at 20uC, with regular population transfers to fresh 15 mm nematode growth medium (NGM) Petri plates inoculated with OP50-1 Escherichia coli. Two independent, age-synchronous populations of each line were generated by bleaching [33]; half of each population was reserved to create line-specific internal controlRelaxed Selection and Oxidative Stressnematodes. All nematodes were maintained on FUdR-containing plates until they were 12 days old, at which point the nematodes were washed in M9 buffer, flash-frozen and stored at 280uC. To minimize DNA oxidation during sample preparation [56], we used the chaotropic sodium iodide method [57] with a DNA Extractor TIS kit (Wako) with lengthened.

Ng from in silico modelling that combined elevation of creatine, TAN and total exchangeable phosphate pools would be favourable to the failing heart [24]. This hypothesis remains untested, since elevating ribose and creatine levels were not sufficient to preserve TAN pool in our murine model of heart failure. This is in contrast to the effect of ribose in models of acute ischaemia and suggests that ribose is not rate-limiting for de novo purine nucleotide synthesis in the failing mouse heart. However, it does not rule out an effect of ribose in heart failure models where the drop in TAN pool is more profound. Other approaches to preserve TAN pool SMER-28 biological activity deserve to be tested, and may yet prove beneficial, for example, inhibition of 59nucleotidase to prevent nucleotide degradation, modulation of glucose-6-phosphate dehydrogenase as the rate limiting enzyme of the pentose phosphate pathway, up-regulation of adenosine kinase, and nucleotide transporter inhibitors.Figure 4. Factors influencing ejection fraction by correlation analysis. Ejection fraction assessed by MRI 8 weeks after myocardial infarction correlated well with infarct size (A), but not with myocardial total adenine nucleotides (B), or myocardial creatine levels (C). Correlation analysis and linear regression is for all groups analysed together. Group MI are untreated wild-type infarcted mice; Group MI+R are wild-type infarcted mice treated with ribose; Group MI+C+R are infarcted creatine transporter overexpressing mice treated with ribose. doi:10.1371/journal.pone.0066461.gmaximal velocity of the creatine kinase reaction still correlate with disease severity in the mouse despite such modest changes [31]. In our study, creatine+ribose supplementation could not prevent the significant 13 fall in TAN pool, but we cannot rule out that this approach might have been effective in SC-66 chemical information attenuating a much larger fall in other species.ConclusionUsing a combination of genetic modification and supplementation we elevated ribose and creatine levels in the mouse heart. This did not prevent gradual loss of total adenine nucleotides in remote myocardium following chronic myocardial infarction and did not protect against cardiac remodelling and development of heart failure.Why did Ribose Supplementation not Maintain TAN Pool in the Failing Heart?Previous studies have shown beneficial effects in acute models of ischaemia where a large and rapid drop in TAN pool occurs as a consequence of nucleotide depletion and subsequent adenosine release [14?6]. This is very different to the slow gradual decline observed in non-ischaemic myocardium in the failing heart, for which the mechanisms are still unclear. One possibility is that suchAuthor ContributionsConceived and designed the experiments: KMEF DA JES CAL SN. Performed the experiments: KMEF DJM DA LSM. Analyzed the data: KMEF DJM DA LSM JES CAL. Contributed reagents/materials/analysis tools: JES. Wrote the paper: KMEF CAL SN.Ribose Treatment in Chronic Murine Heart Failure
Nanoparticles are highly promising candidates for various important biological applications, such as gene delivery [1], cellular imaging [2], and tumor therapy [3]. Meanwhile, the interaction between nanoparticles and the biological systems has received great attention since this may bring some biosafety concerns [4?]. Among numerous types of nanomaterials, carbon nanomaterials have attracted particular interests, such as typical sp2-carbon nanomaterials with hydrophobic surfaces: zero-dimen.Ng from in silico modelling that combined elevation of creatine, TAN and total exchangeable phosphate pools would be favourable to the failing heart [24]. This hypothesis remains untested, since elevating ribose and creatine levels were not sufficient to preserve TAN pool in our murine model of heart failure. This is in contrast to the effect of ribose in models of acute ischaemia and suggests that ribose is not rate-limiting for de novo purine nucleotide synthesis in the failing mouse heart. However, it does not rule out an effect of ribose in heart failure models where the drop in TAN pool is more profound. Other approaches to preserve TAN pool deserve to be tested, and may yet prove beneficial, for example, inhibition of 59nucleotidase to prevent nucleotide degradation, modulation of glucose-6-phosphate dehydrogenase as the rate limiting enzyme of the pentose phosphate pathway, up-regulation of adenosine kinase, and nucleotide transporter inhibitors.Figure 4. Factors influencing ejection fraction by correlation analysis. Ejection fraction assessed by MRI 8 weeks after myocardial infarction correlated well with infarct size (A), but not with myocardial total adenine nucleotides (B), or myocardial creatine levels (C). Correlation analysis and linear regression is for all groups analysed together. Group MI are untreated wild-type infarcted mice; Group MI+R are wild-type infarcted mice treated with ribose; Group MI+C+R are infarcted creatine transporter overexpressing mice treated with ribose. doi:10.1371/journal.pone.0066461.gmaximal velocity of the creatine kinase reaction still correlate with disease severity in the mouse despite such modest changes [31]. In our study, creatine+ribose supplementation could not prevent the significant 13 fall in TAN pool, but we cannot rule out that this approach might have been effective in attenuating a much larger fall in other species.ConclusionUsing a combination of genetic modification and supplementation we elevated ribose and creatine levels in the mouse heart. This did not prevent gradual loss of total adenine nucleotides in remote myocardium following chronic myocardial infarction and did not protect against cardiac remodelling and development of heart failure.Why did Ribose Supplementation not Maintain TAN Pool in the Failing Heart?Previous studies have shown beneficial effects in acute models of ischaemia where a large and rapid drop in TAN pool occurs as a consequence of nucleotide depletion and subsequent adenosine release [14?6]. This is very different to the slow gradual decline observed in non-ischaemic myocardium in the failing heart, for which the mechanisms are still unclear. One possibility is that suchAuthor ContributionsConceived and designed the experiments: KMEF DA JES CAL SN. Performed the experiments: KMEF DJM DA LSM. Analyzed the data: KMEF DJM DA LSM JES CAL. Contributed reagents/materials/analysis tools: JES. Wrote the paper: KMEF CAL SN.Ribose Treatment in Chronic Murine Heart Failure
Nanoparticles are highly promising candidates for various important biological applications, such as gene delivery [1], cellular imaging [2], and tumor therapy [3]. Meanwhile, the interaction between nanoparticles and the biological systems has received great attention since this may bring some biosafety concerns [4?]. Among numerous types of nanomaterials, carbon nanomaterials have attracted particular interests, such as typical sp2-carbon nanomaterials with hydrophobic surfaces: zero-dimen.

These ESC lines required their use as sperm donors for IVF. These observations are suggestive of compromised ESC genomes in the germline. As almost all ESC lines will have developed mutations, it is of crucial importance that F1 offspring be backcrossed even at the expense of slowing throughput, in an attempt to dilute cell culture derived mutations. We suggest that the PH approach more clearly highlights this challenge. Despite this caveat, the PH strategy will raise throughput and efficiency in the production of genetically modified mice.Final CommentThe success of the 10457188 PH approach suggests a number of strategies enabling higher throughput of genetically modified animals from ESCs. In one scheme male PH animals can be paired with females at 7 weeks of age. After a further 2? weeks the males are purchase 223488-57-1 sacrificed, checked for the presence of sperm in the vasa deferentia and epididymis and if present cryopreserved. The occurrence of sperm is strongly indicative that germline Hexaconazole transmission can be achieved. If the previously paired females fail to produce pups, an IVF can be performed using this frozen sperm and scaled to produce the required number of animals. A further crucial benefit of this approach is that when PH animals fail to have sperm rapid closure can be reached and an informed decision can be made in regards as to how to proceed.Table 2. Summary of germline transmission with IKMC lines.GeneIKMC ESC Clone IDESC cloneProviderConventional Host Blastocysts ESC recipents GLT offspring 0/215 0/Perfect Host Blastocysts ESC recipents GLT Failed Failed offspring 0 0 4/4 6/6 11/11 44/44 91/91 18/18 77/77 25/25 36/36 308/308 (100 )FertilePlk1 Plk1 Kdm6b Sdha DRD2 Setd6 Mrps25 Dnajc5g Htr3b Col18a1 GhrhrHEPD0663_7_E04 HEPD0663_7_G03 EPD0330_7_F03 EPD0670_1_C11 HEPD0654_5_E11 DEPD00513_4_C01 12105B-B6 15380A-C6 10050A-F4 15565A-F8 10030C-FJM8A3.N1 JM8A3.N1 JM8A1.N3 JM8A3.N1 JM8A3.N1 JM8A3.N1 VGB6 VGB6 VGB6 VGB6 VGBEucomm Eucomm CSD CSD Eucomm CSD Velocigene Velocigene Velocigene Velocigene VelocigeneFailed Failed Failed Failed Failed GLT GLT GLT GLT GLT GLT 550/12 0/13 1/18 1/18 1/13 3/17 7/25 1/12 7/14 2/12 5/21 16Sterile chimeras *GLT 0/43 0/175 31/70 4/15 4/22 13/42 9/27 20/20 *GLT#GLTGLT GLT GLT GLT GLT GLT81/725 (11 ) 82Summary of data obtained from comparison of conventional vs. PH microinjected with IKMC ESC clones. GLT (germline transmission) is defined as offspring being paternally derived from the introduced ESC as determined by coat color for conventional host derived animals or by SNP genotyping for PH derived animals. Approximately 50 of germline transmission offspring contained the modified allele (data not shown). With this set of 11 ESC clones germline transmission was obtained with 6/11 using conventional host blastocysts vs 9/11 using PH blastocysts as ESC recipients. If we consider only the first litters then using conventional host, 35 (83/240) of offspring in the first litters were donor ESC germline. In comparison, 100 (137/137) of PH males offspring in the first litters were donor germline. Fertile refers to the number of PH putative chimeras which proved to be fertile. *Two ESC lines produced PH chimeric males which were subfertile, producing no offspring by natural mating, however they were found to have sperm in the epididymis which were used post cryopreservation for IVF, providing successful germline transmission. # The HEPD0654_5_E11 ESC line microinjected into PH gave germline transmission however, many of the p.These ESC lines required their use as sperm donors for IVF. These observations are suggestive of compromised ESC genomes in the germline. As almost all ESC lines will have developed mutations, it is of crucial importance that F1 offspring be backcrossed even at the expense of slowing throughput, in an attempt to dilute cell culture derived mutations. We suggest that the PH approach more clearly highlights this challenge. Despite this caveat, the PH strategy will raise throughput and efficiency in the production of genetically modified mice.Final CommentThe success of the 10457188 PH approach suggests a number of strategies enabling higher throughput of genetically modified animals from ESCs. In one scheme male PH animals can be paired with females at 7 weeks of age. After a further 2? weeks the males are sacrificed, checked for the presence of sperm in the vasa deferentia and epididymis and if present cryopreserved. The occurrence of sperm is strongly indicative that germline transmission can be achieved. If the previously paired females fail to produce pups, an IVF can be performed using this frozen sperm and scaled to produce the required number of animals. A further crucial benefit of this approach is that when PH animals fail to have sperm rapid closure can be reached and an informed decision can be made in regards as to how to proceed.Table 2. Summary of germline transmission with IKMC lines.GeneIKMC ESC Clone IDESC cloneProviderConventional Host Blastocysts ESC recipents GLT offspring 0/215 0/Perfect Host Blastocysts ESC recipents GLT Failed Failed offspring 0 0 4/4 6/6 11/11 44/44 91/91 18/18 77/77 25/25 36/36 308/308 (100 )FertilePlk1 Plk1 Kdm6b Sdha DRD2 Setd6 Mrps25 Dnajc5g Htr3b Col18a1 GhrhrHEPD0663_7_E04 HEPD0663_7_G03 EPD0330_7_F03 EPD0670_1_C11 HEPD0654_5_E11 DEPD00513_4_C01 12105B-B6 15380A-C6 10050A-F4 15565A-F8 10030C-FJM8A3.N1 JM8A3.N1 JM8A1.N3 JM8A3.N1 JM8A3.N1 JM8A3.N1 VGB6 VGB6 VGB6 VGB6 VGBEucomm Eucomm CSD CSD Eucomm CSD Velocigene Velocigene Velocigene Velocigene VelocigeneFailed Failed Failed Failed Failed GLT GLT GLT GLT GLT GLT 550/12 0/13 1/18 1/18 1/13 3/17 7/25 1/12 7/14 2/12 5/21 16Sterile chimeras *GLT 0/43 0/175 31/70 4/15 4/22 13/42 9/27 20/20 *GLT#GLTGLT GLT GLT GLT GLT GLT81/725 (11 ) 82Summary of data obtained from comparison of conventional vs. PH microinjected with IKMC ESC clones. GLT (germline transmission) is defined as offspring being paternally derived from the introduced ESC as determined by coat color for conventional host derived animals or by SNP genotyping for PH derived animals. Approximately 50 of germline transmission offspring contained the modified allele (data not shown). With this set of 11 ESC clones germline transmission was obtained with 6/11 using conventional host blastocysts vs 9/11 using PH blastocysts as ESC recipients. If we consider only the first litters then using conventional host, 35 (83/240) of offspring in the first litters were donor ESC germline. In comparison, 100 (137/137) of PH males offspring in the first litters were donor germline. Fertile refers to the number of PH putative chimeras which proved to be fertile. *Two ESC lines produced PH chimeric males which were subfertile, producing no offspring by natural mating, however they were found to have sperm in the epididymis which were used post cryopreservation for IVF, providing successful germline transmission. # The HEPD0654_5_E11 ESC line microinjected into PH gave germline transmission however, many of the p.

Distance travelledEthics statementThis research was conducted in accordance with the Ethical Principles in Animal Research adopted by the National Council for the Control of Animal Experimentation – Brazil (CONCEA?Conselho Nacional de Controle de Experimentacao Animal?Stress-Induced Antinociception in FishFigure 1. Locomotor activity of L. macrocephalus subjected to Argipressin chemical information restraint for 3 and 5 min, followed by subcutaneous injection of 3 formaldehyde. Data are presented as the difference (D) between post-stimulus and baseline. Experimental groups: saline (SAL, n = 8), GNF-7 web formaldehyde (FOR, n = 8), 3 min of restraint + saline (RES (3) + SAL, n = 8), 3 min of restraint + formaldehyde (RES (3) + FOR, n = 8), 5 min of restraint + saline (RES (5) + SAL, n = 8) and 5 min of restraint + formaldehyde (RES (5) + FOR, n = 8). Different letters indicate significant difference (Tukey test, P,0.05). doi:10.1371/journal.pone.0071175.gFigure 2. Time course of the effect of 3 min of restraint on the locomotor activity of L. macrocephalus subjected to subcutaneous injection of 3 formaldehyde. Data are presented as the difference (D) between post-stimulus and baseline. Experimental groups: subcutaneous injection of formaldehyde without restraint (FOR) and applied immediately (0 min, n = 8), 5 (n = 7), 10 (n = 7) or 15 (n = 7) min after the restraint. Different letters indicate significant difference (Tukey test, P,0.05). doi:10.1371/journal.pone.0071175.gand swimming speed were significantly lower than those presented by non-immobilized animals when formaldehyde was applied immediately after the restraint (0 min) and 5 min after the restraint (Tukey, P,0.001). The formaldehyde injections 10 and 15 min after the restraint promoted increases in locomotor activity, and the distance and swimming speed were similar to those presented by non-immobilized animals (Figure 3).Experiment 3: Influence of naloxone pre-treatment on the inhibition of the nociceptive response induced by 3 min of restraintA significant effect of the naloxone intraperitoneal injection (30 mg.kg21) on the inhibition of the nociceptive response induced by 3 min of restraint was observed (ANOVA, F3,28 = 14.65, P,0.001). The naloxone injection 30 min before 3 min of restraint blocked the restraint-induced inhibition of the locomotor response to formaldehyde. In the NAL + RES (3) + FOR group (naloxone-treated animals before the restraint followed by formaldehyde subcutaneous injection), the distance and speed values were significantly higher than those presented by SAL + RES (3) + SAL, SAL + RES (3) + FOR and NAL + RES (3) + SAL (Tukey, P,0.001) (Figure 4 A).Figure 3. Time course of the effect of 5 min of restraint on the locomotor activity of L. macrocephalus subjected to subcutaneous injection of 3 formaldehyde. Data are presented as the difference (D) between post-stimulus and baseline. Experimental groups: subcutaneous injection of formaldehyde without restraint (FOR) and applied immediately (0 min, n = 8), 5 (n = 8), 10 (n = 8) or 15 (n = 7) min after the restraint. Different letters indicate significant difference (Tukey test, P,0.05). doi:10.1371/journal.pone.0071175.gExperiment 4: Influence of naloxone pre-treatment on inhibition of the nociceptive response induced by 5 min of restraintNo effect of the naloxone intraperitoneal injection (30 mg.kg21) on the inhibition of the nociceptive response induced by 5 min of restraint was observed (ANOVA, F3,28 = 0.169, P = 0.916). In the NAL + RES (5.Distance travelledEthics statementThis research was conducted in accordance with the Ethical Principles in Animal Research adopted by the National Council for the Control of Animal Experimentation – Brazil (CONCEA?Conselho Nacional de Controle de Experimentacao Animal?Stress-Induced Antinociception in FishFigure 1. Locomotor activity of L. macrocephalus subjected to restraint for 3 and 5 min, followed by subcutaneous injection of 3 formaldehyde. Data are presented as the difference (D) between post-stimulus and baseline. Experimental groups: saline (SAL, n = 8), formaldehyde (FOR, n = 8), 3 min of restraint + saline (RES (3) + SAL, n = 8), 3 min of restraint + formaldehyde (RES (3) + FOR, n = 8), 5 min of restraint + saline (RES (5) + SAL, n = 8) and 5 min of restraint + formaldehyde (RES (5) + FOR, n = 8). Different letters indicate significant difference (Tukey test, P,0.05). doi:10.1371/journal.pone.0071175.gFigure 2. Time course of the effect of 3 min of restraint on the locomotor activity of L. macrocephalus subjected to subcutaneous injection of 3 formaldehyde. Data are presented as the difference (D) between post-stimulus and baseline. Experimental groups: subcutaneous injection of formaldehyde without restraint (FOR) and applied immediately (0 min, n = 8), 5 (n = 7), 10 (n = 7) or 15 (n = 7) min after the restraint. Different letters indicate significant difference (Tukey test, P,0.05). doi:10.1371/journal.pone.0071175.gand swimming speed were significantly lower than those presented by non-immobilized animals when formaldehyde was applied immediately after the restraint (0 min) and 5 min after the restraint (Tukey, P,0.001). The formaldehyde injections 10 and 15 min after the restraint promoted increases in locomotor activity, and the distance and swimming speed were similar to those presented by non-immobilized animals (Figure 3).Experiment 3: Influence of naloxone pre-treatment on the inhibition of the nociceptive response induced by 3 min of restraintA significant effect of the naloxone intraperitoneal injection (30 mg.kg21) on the inhibition of the nociceptive response induced by 3 min of restraint was observed (ANOVA, F3,28 = 14.65, P,0.001). The naloxone injection 30 min before 3 min of restraint blocked the restraint-induced inhibition of the locomotor response to formaldehyde. In the NAL + RES (3) + FOR group (naloxone-treated animals before the restraint followed by formaldehyde subcutaneous injection), the distance and speed values were significantly higher than those presented by SAL + RES (3) + SAL, SAL + RES (3) + FOR and NAL + RES (3) + SAL (Tukey, P,0.001) (Figure 4 A).Figure 3. Time course of the effect of 5 min of restraint on the locomotor activity of L. macrocephalus subjected to subcutaneous injection of 3 formaldehyde. Data are presented as the difference (D) between post-stimulus and baseline. Experimental groups: subcutaneous injection of formaldehyde without restraint (FOR) and applied immediately (0 min, n = 8), 5 (n = 8), 10 (n = 8) or 15 (n = 7) min after the restraint. Different letters indicate significant difference (Tukey test, P,0.05). doi:10.1371/journal.pone.0071175.gExperiment 4: Influence of naloxone pre-treatment on inhibition of the nociceptive response induced by 5 min of restraintNo effect of the naloxone intraperitoneal injection (30 mg.kg21) on the inhibition of the nociceptive response induced by 5 min of restraint was observed (ANOVA, F3,28 = 0.169, P = 0.916). In the NAL + RES (5.